EAACI Congress 2025
BackFT02 - Anaphylaxis, new perspectives and treatments
Friday 13 Jun, 13:15 PM -
14:45 PM Glasgow, United Kingdom
Dochart 1
Flash Talks
13:15
Risk of Anaphylaxis in Patients with Large Local Reactions to Hymenoptera Stings: Retrospective and Prospective study
13:22
Predictors of Fatal Anaphylaxis: A Systematic Review
13:29
Pharmacokinetics and Pharmacodynamics following repeat dosing of ARS-1 (adrenaline nasal spray) versus intramuscular injection during induced allergic rhinitis: sub-analysis
13:36
The Cross-Canada Registry for Anaphylaxis Fatalities (CRAFT ): Demographics , Triggers, Co-factors and Management
13:43
Development of a Validated, Updated North American Anaphylaxis Management Plan
13:50
Cold-Induced Anaphylaxis: New Perspectives on Clinical and Genetic Characteristics
13:57
Prescription rates of adrenaline autoinjectors in Austria – a population-based study
14:04
Pharmacokinetics by Adrenaline Products from Various Studies
14:11
Adrenaline-use during the acute treatment of anaphylaxis – data from the European Anaphylaxis Registry
14:18
Pollen induces pseudo-allergy via MRGPRX2/Mrgprb2 on mast cells
14:25
Circulating mastocyte-derived prostaglandins in perioperative anaphylaxis
14:32
Risk factors for severe food anaphylaxis; data from the Allergy-Vigilance Network
